Basic Information
RNALocate ID: | RLID:02000508 |
RNA Symbol: | MALAT1 |
Localization: | Nucleus |
RNA Information
RNA Name: | MALAT1 |
RNA ID: | NCBI:378938|Ensembl:ENSG00000251562 |
RNA Category: | lncRNA |
Species: | Homo sapiens |
Alias: | HCN|LINC00047|NCRNA00047|NEAT2|PRO2853 |
Localization Information
PubMed ID: | 30419554 |
Tissue/Cell Line: | Human brain microvascular endothelial cells |
Method: | FISH |
MALAT1 and MDM2 subcellular localization results indicate they both exhibit nuclear expression. Originally published in Cell Physiol Biochem. Zhang T, et al, 2018. Reproduced under the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) |
|
Description: | Results in Fig.3B illustrate that expression levels of p-p53, MDM2 and BAX were all significantly greater than in controls. Cy3 was employed as a fluorescent label to localize MALAT1 and MDM2 within cells. In Fig.3C, we merged images of their fluorescent tags, revealing that both of them exhibited nuclear expression. |
Other Subcellular Localization
RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
RLID:02000386 | Nucleus | ZFL cells | 28538188 |
RLID:02000501 | Chromatin | Breast cancer cell line (SKBR3) | 28652379 |
RLID:02000502 | Cytoplasm | HEK-293T cells|Mammary epithelium cell line (HC11) | 31863590 |
RLID:02000503 | Cytosol | Human myelogenous leukemia cell line (K-562) | 21613539 |
RLID:02000504 | Mitochondrion | HCC cell line (HepG2) | 31218107 |
RLID:02000505 | Nucleus | Human osteosarcoma cell line (U2OS) | 28423669 |
RLID:02000506 | Nucleus | HeLa cells | 28663102 |
RLID:02000507 | Nucleus | WI-38 cells | 29133588 |
RLID:02000509 | Nuclear speckle | Breast cancer cell line (MCF-7) | 28652379 |
RLID:02000510 | Nuclear speckle | Retinal microvascular endothelial cells | 30815547 |
RLID:02000511 | Nuclear speckle | U2OS cells | 31085639 |
RLID:02000512 | Nuclear speckle | HEK-293T cells|Mammary epithelium cell line (HC11) | 31863590 |
RLID:02000513 | Nuclear speckle | HeLa-TO cells | 22355166 |
RLID:02000514 | Nucleoplasm | WI-38 cells | 29133588 |
RLID:02000515 | Nucleus | Human cervical cancer cell line (HeLa) | 28216671 |
RLID:02000516 | Nucleus | U2OS cells | 28538188 |
RLID:02000517 | Nucleus | Breast cancer cell lines (MDA-MB-468|SKBR3) | 28652379 |
RLID:02000518 | Nucleus | HeLa cells | 29335281 |
RLID:02000519 | Nucleus | Lung cancer cell line (A549) | 30548064 |
RLID:02000520 | Nucleus | Vascular smooth muscle cells | 31696492 |
RLID:02000521 | Nucleus | Fibroblasts|Lymphoblasts | 17270048 |
RLID:02000522 | Nucleus | Cell line (HeLa) | 19041754 |
RLID:02000523 | Nucleus | HeLa cells | 20797886 |
RLID:02000524 | Nucleus | Motor neurons | 22070123 |
RLID:02000525 | Nucleus | Human cervical cancer cell line (HeLa) | 22078878 |
RLID:02000526 | Nucleus | CLTon cells | 22855529 |
RLID:02000527 | Nucleus | HeLa cells | 23073843 |
RLID:02000528 | Nucleus | Cell line (HeLa) | 23152763 |
RLID:02000529 | Nucleus | Colon cancer cells | 24393600 |
RLID:02000530 | Nucleus | HeLa cells | 25630241 |
RLID:02001011 | Nucleus | IgH-2 cells|Periphery of seminiferous tubules | 28538188 |
RLID:02001145 | Cytoplasm | Lung cancer cell lines (A549|H1299) | 34012919 |
RLID:12000064 | Exosome | Thyroid papillary carcinoma cell line (TPC-1) | 29967342 |
RLID:12000065 | Exosome | HeLa cells | 24205503 |
RLID:22000052 | Speckle periphery | HeLa cells|WI-38 cells | 29133588 |
RLID-D:02000317 | Chromatin | HeLa-S3 cells|K562 cells | |
RLID-D:02000618 | Cytosol | HCC cell line (HepG2)|HeLa-S3 cells|K562 cells | |
RLID-D:02000717 | Insoluble cytoplasm | K562 cells | |
RLID-D:02000824 | Membrane | HCC cell line (HepG2)|K562 cells | |
RLID-D:02001085 | Nucleolus | K562 cells | |
RLID-D:02001487 | Nucleoplasm | K562 cells | |
RLID-D:02002025 | Nucleus | HCC cell line (HepG2)|HeLa-S3 cells|K562 cells | |
RLID-D:12004468 | Exosome | Serum |
ncRNA Disease Information
Resource | RNA Symbol | Disease | Link |
MNDR | MALAT1 | Anaplastic large cell lymphoma | MNDR-E-LNC-17626 |
MNDR | MALAT1 | Diffuse large b cell lymphoma | MNDR-E-LNC-17627 |
MNDR | MALAT1 | Mantle cell lymphoma | MNDR-E-LNC-17628 |
MNDR | MALAT1 | Oral tongue squamous cell carcinoma | MNDR-E-LNC-17629 |
MNDR | MALAT1 | Oral squamous cell carcinoma | MNDR-E-LNC-17630 |
MNDR | MALAT1 | Fibroma | MNDR-E-LNC-17631 |
MNDR | MALAT1 | Triple negative breast cancer | MNDR-E-LNC-17632 |
MNDR | MALAT1 | Nonalcoholic fatty liver disease | MNDR-E-LNC-17633 |
MNDR | MALAT1 | Anaplastic thyroid cancer | MNDR-E-LNC-17634 |
MNDR | MALAT1 | Prostate cancer | MNDR-E-LNC-17635 |
MNDR | MALAT1 | Silicosis | MNDR-E-LNC-17636 |
MNDR | MALAT1 | Chronic lymphocytic leukemia | MNDR-E-LNC-17637 |
MNDR | MALAT1 | Gastric cancer | MNDR-E-LNC-17638 |
MNDR | MALAT1 | Pre-eclampsia | MNDR-E-LNC-17639 |
MNDR | MALAT1 | Alzheimer disease | MNDR-E-LNC-17640 |
MNDR | MALAT1 | Bladder cancer | MNDR-E-LNC-17641 |
MNDR | MALAT1 | Gestational diabetes | MNDR-E-LNC-17642 |
MNDR | MALAT1 | Seizures | MNDR-E-LNC-17643 |
MNDR | MALAT1 | Lung cancer | MNDR-E-LNC-17644 |
MNDR | MALAT1 | Diabetic cataract | MNDR-E-LNC-17645 |
MNDR | MALAT1 | Parkinson disease | MNDR-E-LNC-17646 |
MNDR | MALAT1 | Primary pulmonary hypertension | MNDR-E-LNC-17647 |
MNDR | MALAT1 | Breast cancer | MNDR-E-LNC-17648 |
MNDR | MALAT1 | Cancer | MNDR-E-LNC-17649 |
MNDR | MALAT1 | Squamous cell carcinoma | MNDR-E-LNC-17650 |
MNDR | MALAT1 | Thyroid cancer | MNDR-E-LNC-17651 |
MNDR | MALAT1 | Pancreatic cancer | MNDR-E-LNC-17652 |
MNDR | MALAT1 | Malignant melanoma | MNDR-E-LNC-17653 |
MNDR | MALAT1 | Atherosclerosis | MNDR-E-LNC-17654 |
MNDR | MALAT1 | Vulva squamous cell carcinoma | MNDR-E-LNC-17655 |
MNDR | MALAT1 | Epithelial ovarian cancer | MNDR-E-LNC-17656 |
MNDR | MALAT1 | Colon cancer | MNDR-E-LNC-17657 |
MNDR | MALAT1 | Hepatitis | MNDR-E-LNC-17658 |
MNDR | MALAT1 | Ovarian cancer | MNDR-E-LNC-17659 |
MNDR | MALAT1 | Laryngeal and hypopharyngeal carcinoma | MNDR-E-LNC-17660 |
MNDR | MALAT1 | Kidney cancer | MNDR-E-LNC-17661 |
MNDR | MALAT1 | Urothelial cancer | MNDR-E-LNC-17662 |
MNDR | MALAT1 | Infantile hemangioma | MNDR-E-LNC-17663 |
MNDR | MALAT1 | Carcinoma endometrioid | MNDR-E-LNC-17664 |
MNDR | MALAT1 | Endometrial carcinoma | MNDR-E-LNC-17665 |
MNDR | MALAT1 | Laryngeal squamous cell cancer | MNDR-E-LNC-17666 |
MNDR | MALAT1 | Endometriosis | MNDR-E-LNC-17667 |
MNDR | MALAT1 | DH1/2 wild-type primary GB tumor | MNDR-E-LNC-17668 |
MNDR | MALAT1 | Astrocytoma | MNDR-E-LNC-17669 |
MNDR | MALAT1 | Glioma | MNDR-E-LNC-17670 |
MNDR | MALAT1 | Gastrointestinal system cancer | MNDR-E-LNC-17671 |
MNDR | MALAT1 | Gallbladder cancer | MNDR-E-LNC-17672 |
MNDR | MALAT1 | Skin squamous cell carcinoma | MNDR-E-LNC-17673 |
MNDR | MALAT1 | Amyotrophic lateral sclerosis | MNDR-E-LNC-17674 |
MNDR | MALAT1 | Osteosarcoma | MNDR-E-LNC-17675 |
MNDR | MALAT1 | Fibrosarcoma | MNDR-E-LNC-17676 |
MNDR | MALAT1 | Ewing sarcoma | MNDR-E-LNC-17677 |
MNDR | MALAT1 | Pancreatic ductal adenocarcinoma | MNDR-E-LNC-17678 |
MNDR | MALAT1 | Liver cancer | MNDR-E-LNC-17679 |
MNDR | MALAT1 | Choriocarcinoma | MNDR-E-LNC-17680 |
MNDR | MALAT1 | Uterine cancer | MNDR-E-LNC-17681 |
MNDR | MALAT1 | Gastric adenocarcinoma | MNDR-E-LNC-17682 |
MNDR | MALAT1 | Esophagus squamous cell carcinoma | MNDR-E-LNC-17683 |
MNDR | MALAT1 | Pulmonary fibrosis | MNDR-E-LNC-17684 |
MNDR | MALAT1 | Pituitary adenoma | MNDR-E-LNC-17685 |
MNDR | MALAT1 | Lung squamous cell carcinoma | MNDR-E-LNC-17686 |
MNDR | MALAT1 | Carcinoma lung non-small-cell | MNDR-E-LNC-17687 |
MNDR | MALAT1 | Lung adenocarcinoma | MNDR-E-LNC-17688 |
MNDR | MALAT1 | Adrenocortical carcinoma | MNDR-E-LNC-17689 |
MNDR | MALAT1 | Follicular thyroid carcinoma | MNDR-E-LNC-17690 |
MNDR | MALAT1 | Papillary thyroid cancer | MNDR-E-LNC-17691 |
MNDR | MALAT1 | Medullary thyroid carcinoma | MNDR-E-LNC-17692 |
MNDR | MALAT1 | Thyroid medullary carcinoma | MNDR-E-LNC-17693 |
MNDR | MALAT1 | Ovarian carcinoma | MNDR-E-LNC-17694 |
MNDR | MALAT1 | Bladder urothelial carcinoma | MNDR-E-LNC-17695 |
MNDR | MALAT1 | Bladder carcinoma | MNDR-E-LNC-17696 |
MNDR | MALAT1 | Hyperglycemia | MNDR-E-LNC-17697 |
MNDR | MALAT1 | Endometrial stromal sarcoma | MNDR-E-LNC-17698 |
MNDR | MALAT1 | Uterine corpus endometrial stromal sarcoma | MNDR-E-LNC-17699 |
MNDR | MALAT1 | Cervical cancer | MNDR-E-LNC-17700 |
MNDR | MALAT1 | Renal cell carcinoma | MNDR-E-LNC-17701 |
MNDR | MALAT1 | Clear cell renal cell carcinoma | MNDR-E-LNC-17702 |
MNDR | MALAT1 | Histiocytoid hemangioma | MNDR-E-LNC-17703 |
MNDR | MALAT1 | Gorham's disease | MNDR-E-LNC-17704 |
MNDR | MALAT1 | Pancreatic carcinoma | MNDR-E-LNC-17705 |
MNDR | MALAT1 | Hilar cholangiocarcinoma | MNDR-E-LNC-17706 |
MNDR | MALAT1 | Cholangiocarcinoma | MNDR-E-LNC-17707 |
MNDR | MALAT1 | Esophageal cancer | MNDR-E-LNC-17708 |
MNDR | MALAT1 | Liver cirrhosis | MNDR-E-LNC-17709 |
MNDR | MALAT1 | HIV | MNDR-E-LNC-17710 |
MNDR | MALAT1 | Lung small cell carcinoma | MNDR-E-LNC-17711 |
MNDR | MALAT1 | Head and neck squamous cell carcinoma | MNDR-E-LNC-17712 |
MNDR | MALAT1 | Kidney diseases | MNDR-E-LNC-17713 |
MNDR | MALAT1 | Myocardial infarction | MNDR-E-LNC-17714 |
MNDR | MALAT1 | Uveal melanoma | MNDR-E-LNC-17715 |
MNDR | MALAT1 | Aortic valve disease | MNDR-E-LNC-17716 |
MNDR | MALAT1 | Ovarian endometrial cancer | MNDR-E-LNC-17717 |
MNDR | MALAT1 | Acute monocytic leukemia | MNDR-E-LNC-17718 |
MNDR | MALAT1 | Bladder transitional cell carcinoma | MNDR-E-LNC-17719 |
MNDR | MALAT1 | Ischemic stroke | MNDR-E-LNC-17720 |
MNDR | MALAT1 | Endometrioid endometrial cancer | MNDR-E-LNC-17721 |
MNDR | MALAT1 | Hepatocellular carcinoma | MNDR-E-LNC-17722 |
MNDR | MALAT1 | Hepatoblastoma | MNDR-E-LNC-17723 |
MNDR | MALAT1 | B-cell lymphoma | MNDR-E-LNC-17724 |
MNDR | MALAT1 | Rheumatoid arthritis | MNDR-E-LNC-17725 |
MNDR | MALAT1 | Retinoblastoma | MNDR-E-LNC-17726 |
MNDR | MALAT1 | Neuroblastoma | MNDR-E-LNC-17727 |
MNDR | MALAT1 | Osteoarthritis | MNDR-E-LNC-17728 |
MNDR | MALAT1 | Retinal degeneration | MNDR-E-LNC-17729 |
MNDR | MALAT1 | Monocytic leukemia | MNDR-E-LNC-17730 |
MNDR | MALAT1 | Chronic myeloid leukemia | MNDR-E-LNC-17731 |
MNDR | MALAT1 | Tongue cancer | MNDR-E-LNC-17732 |
MNDR | MALAT1 | Diabetic retinopathy | MNDR-E-LNC-17733 |
MNDR | MALAT1 | Systemic lupus erythematosus | MNDR-E-LNC-17734 |
MNDR | MALAT1 | Acute myeloid leukemia | MNDR-E-LNC-17735 |
MNDR | MALAT1 | Colorectal cancer | MNDR-E-LNC-17736 |
MNDR | MALAT1 | Nasopharyngeal carcinoma | MNDR-E-LNC-17737 |
MNDR | MALAT1 | Nasopharynx carcinoma | MNDR-E-LNC-17738 |
MNDR | MALAT1 | Diabetes mellitus | MNDR-E-LNC-17739 |
MNDR | MALAT1 | Type 2 diabetes mellitus | MNDR-E-LNC-17740 |
MNDR | MALAT1 | Acute myocardial infarction | MNDR-E-LNC-17741 |
MNDR | MALAT1 | Fatty liver disease | MNDR-E-LNC-17742 |
MNDR | MALAT1 | Multiple myeloma | MNDR-E-LNC-17743 |
MNDR | MALAT1 | Extramedullary myeloma | MNDR-E-LNC-17744 |
MNDR | MALAT1 | Proliferative vitreoretinopathy | MNDR-E-LNC-17745 |
MNDR | MALAT1 | TDP-43 protein human | MNDR-E-LNC-17746 |
MNDR | MALAT1 | Aortic valve calcification | MNDR-E-LNC-17747 |
MNDR | MALAT1 | Ovarian epithelial cancer | MNDR-E-LNC-17748 |
MNDR | MALAT1 | Esophageal squamous cancer | MNDR-E-LNC-17749 |
MNDR | MALAT1 | Bronchopulmonary dysplasia | MNDR-E-LNC-17750 |
MNDR | MALAT1 | Uterine cervical neoplasms | MNDR-E-LNC-17751 |
MNDR | MALAT1 | Diabetic nephropathies | MNDR-E-LNC-17752 |
MNDR | MALAT1 | Nasopharyngeal cancer | MNDR-E-LNC-17753 |
MNDR | MALAT1 | Prostate | MNDR-E-LNC-17754 |
MNDR | MALAT1 | Spinal cord injury | MNDR-E-LNC-17755 |
MNDR | MALAT1 | Flavivirus infections | MNDR-E-LNC-17756 |
MNDR | MALAT1 | Sepsis | MNDR-E-LNC-17757 |
MNDR | MALAT1 | Nk/t cell lymphoma | MNDR-E-LNC-17758 |
MNDR | MALAT1 | Acute lung injury | MNDR-E-LNC-17759 |
MNDR | MALAT1 | Diabetic cardiomyopathies | MNDR-E-LNC-17760 |
MNDR | MALAT1 | Congenital microtia | MNDR-E-LNC-17761 |
MNDR | MALAT1 | Calcific aortic valve disease | MNDR-E-LNC-17762 |
MNDR | MALAT1 | Cardiomyocyte apoptosis | MNDR-E-LNC-17763 |
MNDR | MALAT1 | Cerebral ischemia-reperfusion injury | MNDR-E-LNC-17764 |
MNDR | MALAT1 | Cutaneous squamous cell carcinoma | MNDR-E-LNC-17765 |
MNDR | MALAT1 | Decreased myogenesis | MNDR-E-LNC-17766 |
MNDR | MALAT1 | EndMT-related diseases | MNDR-E-LNC-17767 |
MNDR | MALAT1 | High glucose-induced podocyte injury | MNDR-E-LNC-17768 |
MNDR | MALAT1 | Lymph node metastasis | MNDR-E-LNC-17769 |
MNDR | MALAT1 | Photo-aging | MNDR-E-LNC-17770 |
MNDR | MALAT1 | Plexiform fibromyxoma | MNDR-E-LNC-17771 |
MNDR | MALAT1 | Renal ischemia-reperfusion injury | MNDR-E-LNC-17772 |
RNA Interaction Information
Resource | RNA Symbol | Species | Link | RNALocate ID |
RNAInter | ABCA1 | Homo sapiens | RR00022040 |
TOP